Simplex Trading’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3K Sell
300
-2,700
-90% -$121K ﹤0.01% 7036
2025
Q4
$95.2K Sell
3,000
-9,200
-75% -$287K ﹤0.01% 5055
2025
Q3
$343K Buy
12,200
+800
+7% +$24.2K ﹤0.01% 4297
2025
Q2
$419K Sell
11,400
-600
-5% -$20.7K ﹤0.01% 3700
2025
Q1
$471K Buy
12,000
+5,200
+76% +$234K ﹤0.01% 3458
2024
Q4
$315K Buy
6,800
+2,900
+74% +$131K ﹤0.01% 4015
2024
Q3
$176K Sell
3,900
-16,900
-81% -$804K ﹤0.01% 4644
2024
Q2
$1.02M Buy
20,800
+2,400
+13% +$97.9K ﹤0.01% 2882
2024
Q1
$631K Sell
18,400
-48,200
-72% -$1.74M ﹤0.01% 3611
2023
Q4
$2.45M Buy
66,600
+24,000
+56% +$555K ﹤0.01% 2190
2023
Q3
$863K Buy
42,600
+22,700
+114% +$499K ﹤0.01% 2822
2023
Q2
$407K Buy
19,900
+15,700
+374% +$235K ﹤0.01% 3525
2023
Q1
$63K Sell
4,200
-43,000
-91% -$950K ﹤0.01% 5669
2022
Q4
$1.12M Buy
47,200
+46,000
+3,833% +$1.33M ﹤0.01% 2350
2022
Q3
$42K Buy
1,200
+1,100
+1,100% +$46.7K ﹤0.01% 6679
2022
Q2
$3K Sell
100
-500
-83% -$17.7K ﹤0.01% 9214
2022
Q1
$29K Sell
600
-900
-60% -$49.9K ﹤0.01% 7823
2021
Q4
$116K Buy
1,500
+200
+15% +$20.5K ﹤0.01% 6015
2021
Q3
$170K Hold
1,300
﹤0.01% 5849
2021
Q2
$173K Buy
1,300
+1,240
+2,067% +$144K ﹤0.01% 5922
2021
Q1
$743K Buy
60
+25
+71% +$3.8K ﹤0.01% 2806
2020
Q4
$494K Buy
35
+33
+1,650% +$3.66K ﹤0.01% 3447
2020
Q3
$15K Buy
+2
New +$125 ﹤0.01% 6576
2020
Q2
Sell
-1
Closed -$3K 8385
2020
Q1
$3K Buy
+1
New +$27 ﹤0.01% 7095

Other funds holding TWST

Simplex Trading's TWST Position: Q1 2026 in Review

Simplex Trading reduced its Twist Bioscience (TWST) stake by 32% in Q1 2026, selling an estimated $10.1K and leaving 473 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6682.

Simplex Trading first reported a position in TWST in Q3 2020 and has held it in 12 quarters since. The position peaked at $382K in Q4 2022. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Simplex Trading held 473 shares of Twist Bioscience worth $22.5K as of Q1 2026.
  • Simplex Trading sold 225 Twist Bioscience shares in Q1 2026, an estimated $10.1K.
  • Twist Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6682 holding.
  • Simplex Trading first reported a position in Twist Bioscience in Q3 2020 and has held it in 12 quarters since.
  • Simplex Trading's Twist Bioscience position peaked at $382K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.